RECRUITING

Pancreatic Adenocarcinoma Gene Environment Risk Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

Official Title

The Pancreatic Adenocarcinoma Gene Environment Risk Study -A Prospective Cohort Study of Patients at Risk or Having Pancreatic Disease

Quick Facts

Study Start:2004-01
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00912717

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma
  2. * Subjects with abnormal imaging study (CT, MRI, MRCP, EUS)
  3. * Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition
  4. * Control subject with acute pancreatitis
  5. * Control subject with chronic pancreatitis
  6. * Control subject with biliary obstruction
  7. * Control subject with pancreatic cyst
  8. * Member of a high risk family (≥ 1 close relative with pancreatic cancer)
  9. * Healthy control (without any of the above conditions)
  1. * Under the age of 18 years
  2. * Unable to give informed consent
  3. * Inability to travel to Pittsburgh for in-person enrollment

Contacts and Locations

Study Contact

Randall E Brand, MD
CONTACT
412-623-3105
brandre@upmc.edu
Beth Dudley, MS, MPH, CGC
CONTACT
412-623-3105
dudleyre@upmc.edu

Principal Investigator

Randall E Brand, MD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh
Pittsburgh, Pennsylvania, 15213
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Randall E Brand, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2004-01
Study Completion Date2027-12

Study Record Updates

Study Start Date2004-01
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Pancreatic Cancer